Sumeet A Khetarpal, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Apolipoprotein C-III | 8 | 2020 | 209 | 1.630 |
Why?
|
Triglycerides | 11 | 2021 | 2444 | 1.540 |
Why?
|
Lipoproteins | 5 | 2021 | 871 | 1.400 |
Why?
|
Cholesterol, HDL | 10 | 2018 | 1816 | 1.240 |
Why?
|
Lipase | 4 | 2021 | 320 | 1.210 |
Why?
|
N-Acetylgalactosaminyltransferases | 3 | 2020 | 63 | 0.730 |
Why?
|
Lipolysis | 1 | 2021 | 211 | 0.700 |
Why?
|
Hyperlipoproteinemia Type I | 1 | 2019 | 9 | 0.690 |
Why?
|
Primary Prevention | 2 | 2021 | 1188 | 0.550 |
Why?
|
Secondary Prevention | 1 | 2021 | 1472 | 0.490 |
Why?
|
Open Reading Frames | 1 | 2018 | 818 | 0.480 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2018 | 792 | 0.460 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2021 | 3249 | 0.450 |
Why?
|
Coronary Disease | 6 | 2017 | 5914 | 0.410 |
Why?
|
Mutation, Missense | 2 | 2021 | 2592 | 0.400 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 679 | 0.390 |
Why?
|
Thrombocytopenia | 1 | 2019 | 1172 | 0.380 |
Why?
|
Lipid Metabolism | 4 | 2017 | 1895 | 0.380 |
Why?
|
Cholesterol, LDL | 3 | 2023 | 2392 | 0.350 |
Why?
|
Coronary Vessels | 1 | 2021 | 3114 | 0.340 |
Why?
|
Hematopoiesis | 1 | 2019 | 2056 | 0.340 |
Why?
|
Coronary Artery Disease | 5 | 2021 | 6573 | 0.340 |
Why?
|
Multifactorial Inheritance | 1 | 2018 | 1422 | 0.340 |
Why?
|
Atherosclerosis | 3 | 2021 | 3418 | 0.310 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3408 | 0.270 |
Why?
|
Cardiovascular Diseases | 3 | 2023 | 15645 | 0.270 |
Why?
|
Lipoproteins, VLDL | 2 | 2017 | 198 | 0.260 |
Why?
|
Proteomics | 2 | 2017 | 3913 | 0.260 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2018 | 16036 | 0.220 |
Why?
|
Lipoprotein(a) | 2 | 2021 | 488 | 0.220 |
Why?
|
Homozygote | 3 | 2017 | 1774 | 0.220 |
Why?
|
Apolipoproteins | 2 | 2017 | 328 | 0.200 |
Why?
|
Postprandial Period | 2 | 2021 | 320 | 0.190 |
Why?
|
Lysophosphatidylcholines | 1 | 2021 | 77 | 0.190 |
Why?
|
Aging | 1 | 2019 | 8729 | 0.170 |
Why?
|
Mutation | 5 | 2019 | 30211 | 0.170 |
Why?
|
Phenotype | 7 | 2019 | 16718 | 0.170 |
Why?
|
Amidohydrolases | 1 | 2019 | 160 | 0.160 |
Why?
|
Oligonucleotides, Antisense | 2 | 2023 | 462 | 0.150 |
Why?
|
Gene Frequency | 3 | 2017 | 3621 | 0.150 |
Why?
|
Liposomes | 1 | 2021 | 787 | 0.140 |
Why?
|
Oligonucleotides | 1 | 2019 | 561 | 0.140 |
Why?
|
Mice, Knockout | 6 | 2021 | 14476 | 0.140 |
Why?
|
PPAR gamma | 1 | 2019 | 484 | 0.130 |
Why?
|
Scavenger Receptors, Class B | 1 | 2016 | 85 | 0.130 |
Why?
|
Angiopoietins | 1 | 2016 | 86 | 0.130 |
Why?
|
Apolipoproteins B | 1 | 2017 | 385 | 0.130 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2016 | 90 | 0.130 |
Why?
|
Hypolipidemic Agents | 2 | 2023 | 609 | 0.120 |
Why?
|
Consanguinity | 1 | 2017 | 460 | 0.120 |
Why?
|
Apolipoproteins A | 1 | 2015 | 95 | 0.120 |
Why?
|
Docosahexaenoic Acids | 1 | 2021 | 914 | 0.120 |
Why?
|
Lipoprotein Lipase | 1 | 2015 | 133 | 0.120 |
Why?
|
Immunoblotting | 1 | 2017 | 1647 | 0.110 |
Why?
|
ADAM Proteins | 1 | 2015 | 242 | 0.110 |
Why?
|
Primates | 1 | 2016 | 519 | 0.110 |
Why?
|
Ear, External | 1 | 2014 | 165 | 0.110 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 996 | 0.110 |
Why?
|
Receptors, LDL | 1 | 2016 | 492 | 0.110 |
Why?
|
Molecular Targeted Therapy | 4 | 2023 | 2824 | 0.110 |
Why?
|
Mice | 10 | 2021 | 81912 | 0.110 |
Why?
|
Genes | 1 | 2017 | 1824 | 0.110 |
Why?
|
Genetic Variation | 5 | 2019 | 6611 | 0.100 |
Why?
|
Dyslipidemias | 2 | 2023 | 872 | 0.100 |
Why?
|
Adipocytes | 1 | 2019 | 1197 | 0.100 |
Why?
|
Humans | 28 | 2023 | 767040 | 0.100 |
Why?
|
Animals | 13 | 2023 | 168965 | 0.100 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1604 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4114 | 0.090 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1518 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1197 | 0.090 |
Why?
|
Genes, Regulator | 1 | 2011 | 373 | 0.090 |
Why?
|
5' Untranslated Regions | 1 | 2011 | 255 | 0.090 |
Why?
|
Genotype | 2 | 2017 | 13035 | 0.090 |
Why?
|
Genetic Association Studies | 2 | 2017 | 2744 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2201 | 0.090 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 806 | 0.090 |
Why?
|
Models, Animal | 1 | 2016 | 2121 | 0.080 |
Why?
|
Drug Design | 1 | 2015 | 1045 | 0.080 |
Why?
|
Gene Deletion | 1 | 2017 | 2668 | 0.080 |
Why?
|
Genome-Wide Association Study | 4 | 2018 | 12790 | 0.080 |
Why?
|
Glycosylation | 3 | 2020 | 1099 | 0.080 |
Why?
|
Up-Regulation | 2 | 2015 | 4143 | 0.080 |
Why?
|
Risk Factors | 6 | 2021 | 74886 | 0.080 |
Why?
|
Glycoproteins | 1 | 2016 | 2200 | 0.080 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2011 | 1677 | 0.080 |
Why?
|
Coronary Stenosis | 1 | 2014 | 803 | 0.080 |
Why?
|
Amino Acid Sequence | 2 | 2016 | 13411 | 0.070 |
Why?
|
Male | 17 | 2021 | 364203 | 0.070 |
Why?
|
Liver | 3 | 2021 | 7578 | 0.070 |
Why?
|
Cholesterol | 1 | 2016 | 2905 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 3 | 2023 | 18063 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 2227 | 0.070 |
Why?
|
Middle Aged | 11 | 2021 | 223233 | 0.060 |
Why?
|
Haplotypes | 1 | 2011 | 2722 | 0.060 |
Why?
|
Base Sequence | 1 | 2016 | 12414 | 0.060 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2017 | 127 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2023 | 9245 | 0.060 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9551 | 0.060 |
Why?
|
Alleles | 2 | 2014 | 6893 | 0.060 |
Why?
|
Rats | 2 | 2020 | 23713 | 0.060 |
Why?
|
Gene Expression | 2 | 2019 | 7587 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3667 | 0.060 |
Why?
|
Computer Simulation | 1 | 2017 | 6260 | 0.060 |
Why?
|
Female | 13 | 2021 | 396660 | 0.050 |
Why?
|
Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2021 | 33 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2015 | 12250 | 0.050 |
Why?
|
Pedigree | 2 | 2020 | 4539 | 0.040 |
Why?
|
Cross-Sectional Studies | 3 | 2017 | 26325 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5796 | 0.040 |
Why?
|
Genes, Reporter | 2 | 2015 | 1526 | 0.040 |
Why?
|
Aged | 8 | 2017 | 171319 | 0.040 |
Why?
|
Amino Acid Substitution | 2 | 2016 | 1743 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20741 | 0.040 |
Why?
|
Neuregulins | 1 | 2017 | 36 | 0.040 |
Why?
|
Medical History Taking | 1 | 2021 | 779 | 0.030 |
Why?
|
Thiazolidinediones | 1 | 2019 | 460 | 0.030 |
Why?
|
Pakistan | 1 | 2017 | 299 | 0.030 |
Why?
|
Adult | 6 | 2018 | 223317 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 2 | 2016 | 1965 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2017 | 212 | 0.030 |
Why?
|
Hydrolysis | 1 | 2016 | 645 | 0.030 |
Why?
|
Philadelphia | 1 | 2015 | 270 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2015 | 378 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1029 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2015 | 4280 | 0.030 |
Why?
|
Leucine | 1 | 2016 | 547 | 0.030 |
Why?
|
Brain | 1 | 2021 | 27163 | 0.030 |
Why?
|
Proline | 1 | 2016 | 454 | 0.030 |
Why?
|
Lipogenesis | 1 | 2016 | 217 | 0.030 |
Why?
|
Glycopeptides | 1 | 2015 | 225 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2017 | 704 | 0.030 |
Why?
|
Subtilisins | 1 | 2014 | 80 | 0.030 |
Why?
|
Genetic Code | 1 | 2014 | 139 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 326 | 0.030 |
Why?
|
Toll-Like Receptors | 1 | 2016 | 582 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2017 | 1040 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2015 | 1750 | 0.020 |
Why?
|
Cohort Studies | 4 | 2017 | 41718 | 0.020 |
Why?
|
beta-Galactosidase | 1 | 2012 | 573 | 0.020 |
Why?
|
Fasting | 1 | 2017 | 1607 | 0.020 |
Why?
|
Neoplasms | 1 | 2019 | 22350 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 11923 | 0.020 |
Why?
|
Molecular Weight | 1 | 2012 | 2168 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1188 | 0.020 |
Why?
|
Dietary Fats | 1 | 2017 | 2001 | 0.020 |
Why?
|
Heterozygote | 1 | 2016 | 2794 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3760 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2014 | 1074 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5022 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2448 | 0.020 |
Why?
|
Heart Diseases | 1 | 2021 | 2817 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 2217 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2012 | 1076 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2019 | 3324 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2014 | 1791 | 0.020 |
Why?
|
Biological Transport | 1 | 2012 | 2084 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12823 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2014 | 2189 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2009 | 1494 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4349 | 0.010 |
Why?
|
Risk | 1 | 2016 | 9606 | 0.010 |
Why?
|
Linear Models | 1 | 2014 | 5875 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 22361 | 0.010 |
Why?
|
Exons | 1 | 2009 | 2391 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2015 | 17608 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4780 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21526 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2014 | 4525 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18330 | 0.010 |
Why?
|
Blood Glucose | 1 | 2015 | 6421 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2012 | 3207 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14766 | 0.010 |
Why?
|
Obesity | 1 | 2019 | 13085 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42606 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11513 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2023 | 65295 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59980 | 0.010 |
Why?
|
Signal Transduction | 1 | 2016 | 23621 | 0.010 |
Why?
|
Child | 1 | 2020 | 80771 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 89046 | 0.010 |
Why?
|